Houston; April 9, 2020 – Elligo Health Research, a healthcare-enabling research organization, has partnered with Goldstein & Associates to add research as a care option for their patients in the therapeutic areas of Alzheimer’s, Parkinson’s, dementia, multiple sclerosis, migraines, and more.
“Collaborating with Elligo allows us to bring cutting-edge research to our patients to deliver personalized, patient-focused care,” said Dr. Shahbuddin Mukardamwala, associate physician at Goldstein & Associates. “We are proud to offer the latest research to our patients in our office and are excited that they can remain under our care while benefiting from the innovative treatments clinical studies offer.”
As part of the partnership, Elligo will provide the tools, technology, and expertise needed to facilitate clinical research as treatment in an existing practice. The physicians and staff of Goldstein & Associates will receive specialized training, access to study managers, and the critical infrastructure needed to help ease the burden of conducting research so their focus remains on the quality of patient care.
“Our goal has always been to put the needs of the patient front and center in clinical research,” said Chad Moore, president of Elligo Health Research. “Through our partnership with Goldstein & Associates, we continue our momentum toward making it convenient for patients to access clinical research as a care option across a range of therapeutic areas.”
Only Elligo, powered by IntElligo Research Stack™ clinical web-based technology, can follow the entire patient journey from initial identification for study participation through study conduct and conclusion. IntElligo enables collection of required study source data at the point of care and remote monitoring visits.
About Elligo Health Research
Elligo Health Research, a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. Powered by our Goes Direct® approach and novel IntElligo Research Stack™ clinical technology, our team provides access to the best healthcare experts, patients, and research technologies. We engage physicians and patients who otherwise would not participate in clinical research and accelerate the development of new pharmaceutical, biotechnology, and medical device and diagnostic products. Learn more at elligodirect.com.
Contact Us For More Information: